BAFNA PHARMACEUTICALS
Back to Cashflow Statement
|
BAFNA PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹22 Cr | ₹9.48 Cr | ₹4.95 Cr | ₹9.73 Cr | ₹-14 Cr |
What is the latest Cash Flow from Operating Activities ratio of BAFNA PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹22 Cr |
| Mar2024 | ₹9.48 Cr |
| Mar2023 | ₹4.95 Cr |
| Mar2022 | ₹9.73 Cr |
| Mar2021 | ₹-14 Cr |
How is Cash Flow from Operating Activities of BAFNA PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹22 Cr | 133.38 | |
| Mar2024 | ₹9.48 Cr | 91.50 | |
| Mar2023 | ₹4.95 Cr | -49.09 | |
| Mar2022 | ₹9.73 Cr | Positive | |
| Mar2021 | ₹-14 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹324.7 Cr | -2.8% | 15.6% | 67.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,663.0 Cr | 5.2% | 3.8% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,692.0 Cr | 2.2% | 11.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹143,909.0 Cr | 0.8% | 0.7% | 25.7% | Stock Analytics | |
| CIPLA | ₹107,827.0 Cr | 1.3% | 9.1% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,500.0 Cr | -3.5% | 2.7% | 10.3% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | -2.8% |
15.6% |
67.1% |
| SENSEX | 0.8% |
5% |
-2.5% |
You may also like the below Video Courses